Probabilistic cost-effectiveness comparison of screening strategies for colorectal cancer

ACM Transactions on Modeling and Computer Simulation

Volumn 19, Issue 2, 2009, Pages

  Tafazzoli, Ali ^a,d   Roberts, Stephen ^a,d   Klein, Robert ^b   Ness, Reid ^c   Dittus, Robert ^c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Medical Decision Modeling Inc   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d North Carolina State University   (United States)

Author keywords

Acceptability curves; Colorectal cancer screening strategies; Cost effectiveness analysis; Medical decision making; Net benefit analysis; Probabilistic sensitivity analysis

Indexed keywords

ACCEPTABILITY CURVES; COLORECTAL CANCER SCREENING STRATEGIES; COST-EFFECTIVENESS ANALYSIS; MEDICAL DECISION-MAKING; NET BENEFIT ANALYSIS; PROBABILISTIC SENSITIVITY ANALYSIS;

COST EFFECTIVENESS; COSTS; DECISION MAKING; RANDOM PROCESSES; RANDOM VARIABLES; RISK ANALYSIS; SENSITIVITY ANALYSIS; STOCHASTIC MODELS; UNCERTAINTY ANALYSIS;

COST BENEFIT ANALYSIS;

EID: 67149099129     PISSN: 10493301     EISSN: 15581195     Source Type: Journal    
DOI: 10.1145/1502787.1502789     Document Type: Article

References (39)

1. AL, M. J., VAN HOUT, B. A., MICHEL, B. C., AND RUTTEN, F. F. 1998. Sample size calculation in economic evaluations. Health Econom. 7, 327-335. (Pubitemid 28339961)
2. BRIGGS, A. H. 1999. A Bayesian approach to stochastic cost-effectiveness analysis. Health Econom. 8, 257-261. (Pubitemid 29219090)
3. BRIGGS, A. H., BLACKHOUSE, B., AND O'BRIEN, M. J. 2002a. Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflux disease. Medical Decision Making.
4. BRIGGS, A. H., O'BRIEN, B. J., AND BLACKHOUSE, G. 2002b. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectivenss studies. Annual Rev. Public Health 23, 377-401. (Pubitemid 34508080)
5. CARO, J. J. 2005. Pharmacoeconomic analyses using discrete event simulation. Pharmacoeconom. 23, 323-332. (Pubitemid 40677051)
6. CLAXTON, K., SCULPHER, M., MCCABE, C., BRIGGS, A. H., AKEHURST, R., BUXTON, M., BRAZIER, J., AND O'HAGAN, T. 2005. Probabilistic sensitivity analysis for nice technology assessment: Not an optional extra. Health Econom. 14, 339-347. (Pubitemid 40514748)
7. CUBBAGE, D. F. 2003. Simulation of colorectal cancer: The natural history of the disease. Master of Science Thesis, Department of Industrial Engineering and Graduate Program in Operations Research, North Carolina State University.
8. DEVROYE, L. 1986. Non-Uniform Random Variate Generation. Springer, New York.
9. DOUBILET, P., BEGG, C. B., WEINSTEIN, M. C., BRAUN, P., AND MCNEIL, B. J. 1985. probabilistic sensitivity analysis using Monte Carlo simulation. Medical Decision Making 5, 157-177.
10. EDDY, D. M., HASSELBLAD, V., AND SHACHTER, R. 1990a. A Bayesian method for synthesizing evidence. Int. J. Technol. Assess. Health Care 6, 31-55.
11. EDDY, D. M., HASSELBLAD, V., AND SHACHTER, R. 1990b. An introduction to Bayesian method for meta-analysis: The confidence profile method. Medical Decision Making 10, 15-23. (Pubitemid 20086092)
12. FENWICK, E., CLAXTON, K., AND SCULPHER, M. 2001. Representing uncertainty: The role of costeffectiveness acceptability curves. Health Econom. 10, 779-787. (Pubitemid 34041389)
13. FENWICK, E., O'BRIEN, B. J., AND BRIGGS, A.H. 2004. Cost-Effectiveness acceptability curves - Facts, fallacies and frequently asked questions. Health Econom. 13, 405-415. (Pubitemid 38660390)
14. GELMAN, A., CARLIN, J. B., STERN, H. S., AND RUBIN, B.D. 2004. Bayesian data analysis. In Chapman and Hall.
15. GLICK, H. A., BRIGGS, A. H., AND POLSKY, D. 2001. Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses. Expert Rev. Pharmacoeconom. Outcomes Res. 1, 25-36. (Pubitemid 34649743)
16. GOLD, M. R., SEIGEL, J. E., RUSSELL, L. B., AND WEINSTEIN, M. C. 1996. Cost-Effectiveness in Health and Medicine. Oxford University Press, New York.
17. GRIFFITHS, J., FLANDERS, J., AND SELLS, C. 2003. Mastering Visual Studio . Net. O'Reilly, Paris.
18. HAHN, G. J. AND SHAPIRO, S. S. 1967. Statistical Models in Engineering. John Wiley & Sons, New York.
19. HARDCASTLE, J. D., CHAMBERLAIN, J.O., ROBINSON, M. H., MOSS, S. M., AMAR, S. S., BALFOUR, T.W., JAMES, P. D., AND MANGHAM, C. M. 1996. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348, 1472-1477. (Pubitemid 26400242)
20. KAY, C. L., KULLING, D., HAWES, R. H., YOUNG, J. W., AND COTTON, P. B. 2000. Virtual endoscopy - Comparison with colonoscopy in the detection of space-occupying lesions of the colon. Endoscopy 32, 226-232. (Pubitemid 30103486)
21. KELTON, W. D., SADOWSKI, R. P., AND STURROCK, D. T. 2004. Simulation with Arena. McGraw-Hill Higher Education, Boston.
22. KEWENTER, J., BREVINGE, H., ENGARAS, B., HAGLIND, E., AND AHREN, C. 1994. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results For 68,308 Subjects. Scandinavian J. Gastroenterol. 29, 468-473. (Pubitemid 24144518)
23. KRONBORG, O., FENGER, C., OLSEN, J., JORGENSEN, O. D., AND SONDERGAARD, O. 1996. Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 348, 1467-1471. (Pubitemid 26400241)
24. LAW, A. M. AND KELTON, D. W. 2000. Simulation Modeling and Analysis, 3rd ed. Mcgraw-Hill Higher Education, Boston.
25. LOTHGREN, M. AND ZETHRAEUS, N. 2000. Definition, interpretation and calculation of costeffectiveness acceptability curves. Health Econom. 9, 623-630.
26. MANDEL, J. S., BOND, J. H., CHURCH, T. R., SNOVER, D. C., BRADLEY, G. M., SCHUMAN, L.M., AND EDERER, F. 1993. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. New England J. Medicine 328, 1365-1371.
27. MANDEL, J. S., CHURCH, T. R., BOND, J. H., ERDERER, F., GEISSER, M. S., MONGIN, S. J., SNOVER, D. C., AND SCHUMAN, L. M. 2000. The effect of fecal occult-blood screening on the incidence of colorectal cancer. Gastroenterol. 343, 1603-1607. (Pubitemid 32162983)
28. MANNING, W. G., FRYBACK, D. G., AND WEINSTEIN, M. C. 1996. Reflecting uncertainty in costeffectiveness analysis. In Cost-Effectiveness in Health and Medicine, M. R. Gold et al. Eds. Oxford University Press, New York, 247-275.
29. NESS, R. M., HOLMES, A. M., KLEIN, R., AND DITTUS, R. 2000. Cost-Utility of one-time colonoscopic screening for colorectal cancer at various ages. Amer. J. Gastroenterol. 95, 1800-1811. (Pubitemid 30485022)
30. O'BRIEN, B. J., DRUMMOND, M. F., LABELLE, R. J., AND WILLAN, A. 1994. In search of power and significance: Issues in the design and analysis of stochastic Cost-effectiveness studies in health care. Medical Care 32, 150-163.
31. PICKHARDT, P. J., CHOI, R., HWANG, I., BUTLER, J., PUCKETT, M. L., HILDEBRANDT, H. A., WONG, R. K., NUGENT, P. A., MYSLIWIEC, P. A., AND SCHINDLER, W. R. 2003. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. New England J. Medicine 349, 2191-2200. (Pubitemid 37485135)
32. PIGNONE, M., RUSSELL, L., AND WAGNER, J. 2005. Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. The National Academies Press, Washington, D.C.
33. PIGNONE, M., SAHA, S., HOERGER, T., AND MANDELBLATT, J. 2002. Cost-Effectiveness analyses of colorectal cancer screening: A systematic review for the U.S. Preventive Services Task Force. Ann. Internal Medicine 137, 96-104. (Pubitemid 34779153)
34. ROBERTS, S. D. 2004. Simulation input without data. In Proceedings of 6th Annual Simulation Solutions Conference.
35. ROBERTS, S. D., WANG, L., KLEIN, R. L., NESS, R. M., AND DITTUS, R. S. 2008. Development of a simulation model of colorectal cancer. Trans. Modeling Comput. Simul. to appear in January.
36. STINNETT, A. A. AND MULLAHY, J. 1998. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 18, S68-S80. (Pubitemid 28175944)
37. TAFAZZOLI, A. 2004. Acomparison of screening methods for colorectal cancer, master of science, department of industrial engineering and graduate program in operations research, North Carolina State University.
38. U.S. CENSUS BUREAU. 2004. U.S. interim projections by age, sex, race, and hispanic origin. U.S. Census Bureau, http://www.census.gov/ipc/www/ usinterimproj/.
39. WINAWER, S., FLETCHER, R. H., REX, D., BOND, J., BURT, R., FERRUCCI, J. T., GANIATS, T. G., LEVIN, T., WOOLF, S. H., JOHNSON, D., KIRK, L., LITIN, S., SIMMANG, C., AND GASTROINTESTINAL CONSORTIUM PANEL. 2003. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterol. 124, 544-560. (Pubitemid 36169269)